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Abstract
Background: Globally, diabetes is estimated to affect 246 million people and is increasing. In Australia diabetes has
been made a national health priority. While the direct costs of treating diabetes are substantial, and rising, the
indirect costs are considered greater. There is evidence that interventions to prevent diabetes are effective, and
cost-effective, but the impact on labour force participation and income has not been assessed. In this study we
quantify the potential impact of implementing a diabetes prevention program, using screening and either
metformin or a lifestyle intervention on individual economic outcomes of pre-diabetic Australians aged 45-64.
Methods: The output of an epidemiological microsimulation model of the reduction in prevalence of diabetes
from a lifestyle or metformin intervention, and another microsimulation model, Health&WealthMOD, of health and
the associated impacts on labour force participation, personal income, savings, government revenue and
expenditure were used to quantify the estimated outcomes of the two interventions.
Results: An additional 753 person years in the labour force would have been achieved from 1993 to 2003 for the
male cohort aged 60-64 years in 2003, if a lifestyle intervention had been introduced in 1983; with 890 person
years for the equivalent female group. The impact on labour force participation was lower for the metformin
intervention, and increased with age for both interventions. The male cohort aged 60-64 years in 2003 would have
earned an additional $30 million in income with the metformin intervention, and the equivalent female cohort
would have earned an additional $25 million. If the lifestyle intervention was introduced, the same male and
female cohorts would have earned an additional $34 million and $28 million respectively from 1993 to 2003. For
the individuals involved, on average, males would have earned an additional $44,600 per year and females an
additional $31,800 per year, if they had continued to work as a result of preventing diabetes.
Conclusions: In addition to improved health and wellbeing, considerable benefits to individuals, in terms of both
additional working years and increased personal income, could be made by introducing either a lifestyle or
metformin intervention to prevent diabetes.
Background
Globally, diabetes is estimated to affect 246 million people
(2007 figure), with this figure expected to reach 380 mil-
lion by 2025 [1]. The increase has been attributed to
increases in obesity and sedentary lifestyles, and the ageing
of the global population [2,3]. In Australia, the prevalence
of obesity has increased from 43% of the population aged
15 and over in 1995 to 60% in 2007-08 [4] and has been
identified as the largest contributor to the burden of dis-
ease associated with diabetes [5]. Diabetes has been made
a national health priority area in recognition of the perso-
nal and public costs of the disease [6]. The cost of treating
diabetes is expected to rise by 436% (or $7 billion, in
Australian currency) from 2003 to 2033 [7]. However,
while the direct costs of treating diabetes are expected to * Correspondence: megan.passey@ucrh.edu.au
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[2].
The indirect costs are mostly attributed to lost work-
force participation and productivity [2,8]. Within Australia
37.9% of people aged 45-64 who identify diabetes as their
main health condition are not in the labour force, com-
pared with only 30% of all those aged 45-64 [9]. People
who retire early due to diabetes are less likely to have any
financial assets (such as superannuation, investment prop-
erties and equity in their own homes), and if they do, the
value of their assets is around 90% less, than those who
remain in the labour force full time with no chronic health
problem [10]. Other studies have identified the significant
costs that lost income following early retirement due to
poor health have at the national level [11].
People with impaired fasting glucose or impaired glu-
cose tolerance are at high risk of developing type 2 dia-
betes and are considered pre-diabetic [12]. Several
studies have demonstrated that interventions preventing
(or delaying) the development of type 2 diabetes in high
risk individuals are effective [13-15]. Recently, Bertram
et al. investigated the health impacts and health costs of
a number of interventions to prevent diabetes. They
concluded that screening to identify people with pre-
diabetes, followed by treatment with metformin or diet
and exercise for those at risk were the most cost-effective
interventions in preventing or delaying the onset of dia-
betes [16]. In addition to health benefits, prevention of
diabetes would reduce the costs associated with early
retirement due to diabetes.
This study will build upon the findings of Bertram et al.
and estimate the impact on labour force participation and
personal income of a diabetes prevention intervention
using screening and treatment (metformin or a lifestyle
intervention targeting diet and exercise) in pre-diabetic
Australians aged 45-64. The age group of 45-64 year olds
is considered particularly important as this age group has
a high rate of early retirement and will make up an
increasing proportion of the working population as
Australia’s population ages [17].
Methods
We estimated the extra number of years in the labour
force of people aged 45-64 years in 2003 who would not
have developed diabetes if a screening and intervention
program to prevent the onset of diabetes were in place
for the 20 years from 1983. We further estimated the
potential increase in their personal incomes as a result
of staying in the workforce.
Diabetes and labour force participation
Prevalence of diabetes estimates were based on the Aus-
tralian Bureau of Statistics (ABS) Surveys of Disability,
Ageing and Carers (SDAC) conducted in 1993, 1998
and 2003. Chronic health conditions were self reported
in the surveys and were grouped according to the ABS
classification of chronic health conditions which were
based on International Classification of Diseases, Ver-
sion 10 (ICD-10) codes for the 1998 and 2003 surveys
and ICD-9 codes for the 1993 survey. The prevalence of
self reported diabetes was estimated for each year from
1993 to 2003 for each 5 year age group of the baseline
population aged 25 to 44 years old in 1983. For non-
survey years, the prevalence of self reported diabetes
and the total population were first estimated using lin-
ear interpolation from the two nearest surveys and then
the number of self reported diabetes cases was esti-
mated. The prevalence of self-reported diabetes was not
estimated before 1993 as there were no SDAC data
available prior to this time.
Using the 2003 Survey of Disability, Ageing and Carers,
differences in probabilities of the labour force participation
of those without diabetes and of those with diabetes were
estimated for each 5 year age and gender group, adjusted
for highest level of education attained. Labour force parti-
cipation was defined as being either employed or looking
for work. People who were neither employed nor looking
for work were categorised as “out of the labour force”.
In order to estimate additional income that would have
been accumulated had the screening and intervention
been in place since 1983, we derived income estimates of
the individuals from Health&WealthMOD,w h i c hi s
Australia’s first microsimulation model of health and dis-
ability, the associated impacts on labour force participa-
tion, personal income, savings, government revenue and
expenditure [18]. This model was specifically designed to
measure the economic impacts of ill health on Australian
workers aged 45 to 64 years; information which was pre-
viously unavailable.
The base population of Health&WealthMOD was unit
record data extracted from the Survey of Disability, Ageing
and Carers conducted by the Australian Bureau of Statis-
tics in 2003 [19]. From this dataset, individual records
were extracted for those aged 45-64 years. The details
extracted for each individual in the base population
included demographic variables (for example, age, sex,
family type, state of residence, and ethnic background),
socioeconomic variables (level and field of education,
income, benefits received), labour force variables (labour
force participation, employment restrictions, retirement),
and health and disability variables (chronic conditions,
health status, type and extent of disability, support and
care required).
Using a separate microsimulation model–STINMOD–
additional economic information such as individual
income, government support payments and tax liability
was imputed onto the base data. STINMOD is Australia’s
leading model of income tax and government support
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the Australian Government by the National Centre for
Social and Economic Modelling. Income and wealth
information was imputed onto the base population of
Health&WealthMOD by identifying persons with similar
characteristics on STINMOD and “donating” their
income and wealth information onto Health&Wealth-
MOD using a process commonly used in microsimula-
tion modelling called synthetic matching [22]. Nine
variables: sex (2 groups), income unit type (4 groups),
type of government pension/support (3 groups), income
quintile (5 groups), age group (4 groups), labour force
status (4 groups), hours worked per week (5 groups),
highest educational qualification (2 groups) and home
ownership (2 groups), that were common to both data-
sets and strongly related to income were chosen as
matching variables for synthetic matching.
The data were then aged to reflect the 2009 Australian
45 to 64 year old population. The up-rating was used to
account for the disability and illness, demographic, labour
force, earnings growth and other changes that had
occurred between 2003 and 2009.
Income estimates from Health&WealthMOD, which
were in 2009 dollars, were converted to 2003 dollars by
adjusting for the change in consumer price indices from
2003 to 2009. Difference between median incomes,
adjusted for age group and highest education, of those
who were in the labour force and had no diabetes, and of
those who were not in the labour force and had diabetes
was considered as an estimated additional income an indi-
vidual would have if the person did not develop diabetes
because of the intervention and remained in the labour
force.
Reduction in the prevalence of diabetes due to
interventions
An epidemiological microsimulation model was used to
predict the percentage reduction in the prevalence of bio-
chemically confirmed diabetes that would have been
achieved if a screening program for pre-diabetes and met-
formin or lifestyle intervention for those identified with
pre-diabetes had been in place for the twenty years start-
ing from 1983. Full details of the model are available else-
where [16]. Briefly, it is a discrete time microsimulation
model which models the 2003 cohort of Australian people
free of diabetes. These people may have normal glucose
tolerance or pre-diabetes. This model allows people to
progress from normal glucose tolerance to pre-diabetes
and then diabetes. Progression through disease states is
governed by epidemiological data from the Australian Bur-
den of Disease and Injury study and from a study on the
epidemiology of pre-diabetes [5,23]. These disease para-
meters were back cast to 1983 to enable the screening pro-
gram to be modelled for 20 years. People who are aged 45
or over with one or more risk factors for diabetes, (includ-
ing overweight or obesity, family history of type 2 diabetes
and previous gestational diabetes); who are Indigenous
Australians; or who are over 55 years of age were eligible
for a screening program to identify pre-diabetes. We mod-
elled 65% of GPs participating in a screening program,
based on the number of GPs who participate in the cur-
rent practice incentive program for diabetes [24]. We then
assumed that they would ask 80% of those eligible for
screening to participate and that 70% of these people
would agree to participate in screening (based on a
National Heart Foundation consensus panel) [25]. We
assumed that, if identified as pre-diabetic, they would then
be treated with either metformin or a lifestyle change
intervention addressing diet and exercise. Reductions in
diabetes prevalence were predicted for every year from
1984 to 2003 for each 5 year age group of the population,
who were 25 to 44 years old in 1983 and who would have
been 45 to 64 years old in 2003.
Although the epidemiological microsimulation model
predicted the percentage reduction in the prevalence of
diabetes due to interventions from 1983 to 2003, we only
estimated the impacts of interventions on increased labour
force participation and additional incomes from 1993 to
2003. This is for two reasons. The first reason is the lack
of survey data, on which we based our estimates of dia-
betes prevalence, for the years prior to 1993. SDAC data
were available only for the three last surveys conducted in
1993, 1998 and 2003. The second reason is that a large
proportion of the baseline population of 25 to 44 years old
are not eligible for screening for pre-diabetes as one needs
to be 45 years or over to become eligible; the age cohorts
gradually became eligible through the period 1983-2003.
Assumptions
In order to model additional person years in the labour
force and consequently additional income as a result of
the screening program for pre-diabetes and the interven-
tion for those identified as pre-diabetic for the twenty
years starting from 1983, the following assumptions are
made:
1. The percentage reduction in the prevalence of bio-
chemically confirmed diabetes each year because of the
screening and intervention program are the same as the
percentage reduction in the prevalence of self-reported
diabetes for the respective years.
2. Differences in the labour force participation rates,
adjusted for highest education, of those with no diabetes
and with diabetes have not changed over the years.
Simulation
We first estimated the reduction in the number of self-
reported diabetes cases (i.e. extra number of diabetes
free persons) in each year from 1993 to 2003 for each
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in biochemically confirmed diabetes prevalence for the
respective age cohort to the number of self reported dia-
betes cases in each year for the same age cohort. The
number of additional persons in the labour force each
year was then calculated by applying age group specific
differences in the probability of labour force participa-
tion of those without diabetes and of those with diabetes
to the extra number of diabetes free persons of the same
age group. For example, for the cohort who were 60 to
64 years old in 2003, the extra number of diabetes free
persons in 1993, 1998 and 2003 were respectively multi-
plied by the differences in the probability for age groups
50 to 54, 55 to 59 and 60 to 64 years to estimate the
extra number of persons in the labour force in 1993,
1998 and 2003 for this cohort due to the screening pro-
gram and interventions. The total extra person years in
the labour force from 1993 to 2003 for each cohort was
then multiplied by the adjusted difference in median
incomes of those who were in the labour force and had
no diabetes, and of those who were not in the labour
force and had diabetes to estimate the additional income
(in 2003 dollars) that would have been accumulated by
each cohort over the ten years from 1993 to 2003. In
o r d e rt os i m u l a t et h er e s u l t sf o rt h ee n t i r eA u s t r a l i a n
population of age group 45 to 64 years, we performed a
weighted analysis using the weights assigned by the ABS
to each survey record which represented the number of
similar individuals in the Australian population. All
modelling was done separately for males and females,
and for the two interventions; lifestyle and pharmaceuti-
cal intervention using metformin.
Ethical approval was not required, but the research con-
formed to the Helsinki Declaration http://www.wma.net/
en/30publications/10policies/b3/, and to local Australian
legislation. The base data used for this modelling came
from the Australian Bureau of Statistics and are available
to researchers on request.
Results
The likelihood of developing diabetes increases with age
(Figure 1) and over time, with an increasing trend in the
prevalence of diabetes within each age group. The preva-
lence of diabetes for males aged 50-54 years old is 1.68%
in 1993 compared to 4.46% in 1998 and 5.51% in 2003.
Although the prevalence is slightly lower for females com-
pared to males, the trends in prevalence are similar for
both genders.
Table 1 shows the reduction in the prevalence of dia-
betes due to metformin or lifestyle interventions. The
effects of the interventions in reducing the prevalence of
diabetes are nil in the years prior to 1993 (not shown in
Table 1), except for the male cohort aged 40 to 44 years
old at baseline, for whom the reduction in prevalence
started in 1987 (not shown in Table 1). Thus, our analysis
restricted to the years from 1993 to 2003 estimates all of
the impacts of the interventions except for the impacts
o nt h em a l ec o h o r t ,w h ow e r e4 0t o4 4y e a r so l da t
baseline.
People who have diabetes have less probability of
being in the labour force than those who do not have
diabetes for all age groups. While the differences in
these probabilities are similar for all male age groups
between 40 and 64 years, they are dependent upon age
for females, with females aged 50-54 and 55-59 years
having larger difference than females aged 45-49 and
60-64 years old (Table 2).
The results in Table 3 show the outcomes that could
have been achieved over the ten years from 1993 to
2003 if the screening program for pre-diabetes and
either a metformin or lifestyle intervention were adopted
in 1983 to prevent diabetes developing. For males who
were aged 60-64 years in 2003, if a metformin interven-
tion had been introduced in 1983, this age group cumu-
latively would have an additional 683 person years in
the labour force due to the prevention of diabetes. For
the same male age group, if a lifestyle intervention had
been introduced in 1983, by 2003 this group would have
had an additional 753 person years in the labour force
due to diabetes prevention. The impact on labour force
participation is slightly less for females of the same age
group, and increases with age, as the interventions pre-
vent more people developing diabetes in older age.
Figure 1 Prevalence of diabetes by age-sex cohort.
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pharmaceutical intervention of using metformin, with
the lifestyle intervention giving an additional 3,038 per-
son years in the labour force compared to 2,612 person
years due to the metformin intervention over the same
ten year period.
As labour force participation would have been higher
with either of the interventions, so too would the
incomes produced. There would have been an additional
$44,600 per man and $31,800 per woman on average for
each year if they had continued to work as a result of
preventing the onset of diabetes. An additional $30
Table 1 Percentage reduction in the prevalence of biochemically confirmed diabetes due to interventions
Age group at baseline (in 1983) Year
1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003
Pharmaceutical intervention using metformin
Male 25-29 000000000 0.42 0.41
30-34 0000000 0.43 0.63 0.83 0.96
35-39 0 0.24 0.23 0.23 0.30 0.45 0.44 0.86 1.41 1.36 1.65
40-44 0.64 0.94 1.24 1.53 1.45 1.65 1.85 2.15 2.43 2.07 2.13
Female 25-29 000000000 0.28 0.27
30-34 000000000 0.41 0.40
35-39 0.35 0.34 0.66 1.29 1.14 1.12 1.32 1.29 1.46 1.40 1.53
40-44 0.49 0.48 1.18 1.63 1.20 1.34 1.48 1.62 2.07 1.69 1.90
Lifestyle intervention
Male 25-29 000000000 0.62 0.61
30-34 000000 0.22 0.64 0.85 0.97 1.09
35-39 0.24 0.48 0.47 0.46 0.45 0.60 0.73 1.01 1.84 1.67 1.75
40-44 0.64 1.10 1.24 1.53 1.45 1.65 2.06 2.15 2.86 2.40 2.46
Female 25-29 000000000 0.28 0.27
30-34 000000000 0.41 0.40
35-39 0.35 0.68 0.99 1.62 1.37 1.35 1.54 1.50 1.67 1.71 1.84
40-44 0.49 0.48 1.18 1.63 1.37 1.51 1.81 1.94 2.38 1.94 2.02
Table 2 Labour force participation rates of people
without diabetes and with diabetes and with differences
in participation rates adjusted for highest education
level, SDAC 2003
Without diabetes With diabetes Difference
#
Male 40-44 0.93 0.81 0.10
45-49 0.90 0.74 0.16
50-54 0.88 0.78 0.10
55-59 0.77 0.64 0.12
60-64 0.59 0.45 0.13
Female 40-44 0.77 0.43 0.30
45-49 0.79 0.69 0.10
50-54 0.70 0.43 0.27
55-59 0.52 0.21 0.33
60-64 0.30 0.22 0.09
#Differences were adjusted for highest education attained
Table 3 Increased number of person years in the labour
force & the associated increased in total incomes over
the ten years from 1993 to 2003 due to the interventions
Age group in
2003
Over ten years
Total person
years
Total incomes (2003
dollars)
For pharmaceutical intervention using metformin
Male 45-49 28 1,263,000
50-54 97 4,319,000
55-59 282 12,578,000
60-64 683 30,486,000
Female 45-49 11 347,000
50-54 42 1,329,000
55-59 679 21,629,000
60-64 790 25,144,000
Total 2,612 97,095,000
For lifestyle intervention
Male 45-49 43 1,896,000
50-54 125 5,595,000
55-59 358 15,967,000
60-64 753 33,599,000
Female 45-49 11 347,000
50-54 42 1,329,000
55-59 816 25,983,000
60-64 890 28,334,000
Total 3,038 113,049,000
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ten year period from 1993 to 2003 by the male cohort,
who were 60-64 years old in 2003 if the metformin
intervention was introduced in 1983, and an additional
$25 million for the same time period for the equivalent
female cohort (Table 3). If the lifestyle intervention was
introduced in 1983, the same male and female cohorts
would have achieved an additional $34 million and $28
million respectively in income over the ten year period
from 1993 to 2003. For all cohorts, the metformin inter-
vention would have resulted in an additional $97 million
in income, and the lifestyle intervention in an additional
$113 million.
Discussion
I nt h i sp a p e rw eh a v ee s t i m a t e dt h ep o t e n t i a li m p a c to f
diabetes prevention programs on labour force participa-
tion and income generation among people at high risk of
developing diabetes. The results show that considerable
benefits, in terms of both additional working years and
increased personal income, could be made by introducing
either a lifestyle or metform i ni n t e r v e n t i o nt op r e v e n t
diabetes. Up to an additional $113 million in total perso-
nal income between the years 1993 and 2003 could have
been generated if a lifestyle intervention was implemen-
ted in 1983. While this amount is small relative to total
income for this age group (income for this age group was
$172 billion in 2003–results not shown), for the indivi-
duals involved, the impact is considerable.
Our results should be considered a minimal estimate of
the impact of diabetes prevention interventions due to
the conservative approach taken. Firstly, we have only
captured the lost working years and income among those
who retire. Among those who continue in the workforce,
diabetes is likely to further reduce productivity through a
shift to part-time or lower paid work as a result of the ill-
ness and its complications [26]. Indeed Schofield et al.
have shown that those with diabetes have significantly
lower incomes than those with no long term health con-
dition regardless of labour force status [11]. Secondly, the
assumptions used for estimating reductions in prevalence
were based on conservative levels of participation in the
screening program by both GPs and consumers. If parti-
cipation rates could be increased, there would be greater
reductions in the incidence of diabetes with consequent
increases in workforce participation. Thirdly, in the case
of the lifestyle intervention there are likely to be addi-
tional benefits through reductions in obesity and other
diseases such as cardiovascular disease and cancer, which
have not been considered in our modelling.
A limitation of the approach taken is that we have
assumed that the reduction in self-reported prevalence of
diabetes from a diabetes intervention would be similar to
the reduction in biochemically confirmed diabetes.
Although this seems plausible, it has not been validated.
A further limitation is that our approach implies a causal
relationship between having diabetes and the reduced
rate of labour force participation among those with dia-
betes, relative to those without. It is possible that some
other factor is confounding the relationship and may be
reducing the labour force participation of those with dia-
betes. Diabetes, as well as risk factors for diabetes (such
as obesity, physical inactivity and smoking) are more
common in lower socio-economic groups [4]. By control-
ling for education level in the analysis, we aimed to mini-
mise the potential for confounding by other socio-
economic factors, or by other diseases which are also pre-
valent among lower socio-economic groups. However,
the possibility of confounding by unknown factors cannot
be excluded. Additionally, the possibility of reverse caus-
ality cannot be completely excluded–that is, that early
retirement has led to development of diabetes. However,
the French GAZEL study provides interesting results
which suggest this is unlikely. This longitudinal, repeat-
measures study over 15 years has found that having dia-
betes increases the risk of transition from employment to
disability and retirement [27], but that retirement did not
change the risk of developing a number of chronic dis-
eases, including diabetes [28].
Several other studies have estimated the indirect cost
of diabetes attributed to lost labour force participation,
both through temporary absenteeism and permanent
retirement due to ill health [29-32]. A US study esti-
mated lost productivity costs of US$2.6 billion due to
diabetes related absenteeism from work, and US $7.9
billion due to unemployment from diabetes related dis-
ability in 2007 [33]. Similarly, the indirect costs of dia-
betes were estimated to be 70.1 million EURO in
Norway in 2005 [31]. Studies that have analysed the
indirect costs of diabetes have mainly used the human
capital approach [34], which is consistent with the
approach we have taken in our study. However, these
previous studies assessed the cost of illness, and did not
consider the financial benefits of treatment. Our study
estimates the potential productivity benefits of interven-
tions to prevent diabetes using a microsimulation model
to estimate the reduction in the prevalence of diabetes
likely to be achieved through these interventions and
linking this to models of the impact of diabetes on
labour force participation.
The benefit of increased labour force participation as a
result of preventing diabetes is likely to extend beyond
the individual, and provide some medium-term benefit
to government also. Previous studies have shown that in
the 45 to 64 year age group diabetics pay 67% less tax
than non-diabetics, and receive 112% more in social
security payments each week than non-diabetics [11].
This is in addition to the $989 million that the
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for diabetes (based on figures for the 2004-05 period)
and the additional $7 billion that is projected to be
spent between 2003 and 2033 [7,35]. Preventing diabetes
is therefore likely to have considerable financial benefits
to governments in the medium-term. While, the future
costs to government of caring for subsequent illness
among people whose death has been delayed are not
considered in this analysis, it is the accepted responsibil-
ity of government to optimise the wellbeing of the
population [36,37].
In the future, the benefits of diabetes prevention pro-
grams are likely to be greater, as diabetes is both increas-
ing in prevalence worldwide, and becoming more
common among the working-age population, particularly
those aged 45 to 64 years [38]. Keeping greater numbers
of experienced, older workers in the labour force is
increasingly becoming a priority of governments. Key
government reports have highlighted population ageing
and labour shortages as potential pressures threatening
the Australian economy [17]. Such a situation is likely to
be reflected internationally in most developed countries,
with the ageing of the global population [39].
The modelling undertaken assumes that the individuals
who benefit from diabetes prevention would participate
in the labour force at the same rate as other individuals
without diabetes, controlling for education. Unlike many
industrialised countries, Australia has low unemployment
and labour shortages in a number of industries. In 2009,
Australia’s unemployment rate was 5.8%–close to the
accepted ‘full employment’ rate of 5% [40]. In his 2011
budget speech, the treasurer emphasised the high
employment rate: “Over 300,000 jobs have been created
in the past year and the unemployment rate is forecast to
fall further, to 4 1/2 per cent by mid 2013, creating
another half a million jobs.... We believe our economy
can’t afford to waste a single pair of capable hands.” [41]
It is therefore likely that those who benefit from diabetes
prevention would be able to find employment as easily as
others.
Early retirement due to ill health is a problem through-
out the world, and in Australia it is estimated that 58% of
men and 26% of women who retire from full-time work
early (that is, before the age of 55 years–from 55 years of
age Australian citizens can access preserved superannua-
tion and are entitled to some social security pensions) do
so because of ill health [42]. Maintaining the health of the
workforce is seen as a vital step in securing the economic
activity of the nation [17]. The government has promoted
deferred or gradual retirement as a solution, and given the
numbers retiring due to illness, the prevention and treat-
ment of long-term health conditions may be critical in
helping older Australians to remain in the workforce
longer [42]. There is also likely to be a widening gap
between Australians who are able to work and those who
retire prematurely when they become ill, in terms of both
income earned and assets accumulated.
Conclusions
This study suggests that prevention of diabetes with
metformin or lifestyle interventions will have significant
benefits for boosting labour force participation, and also
increasing incomes for individuals.
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